TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common stock, $0.001 par value
Symbol
TMCI on Nasdaq
Shares outstanding
63,703,704
Price per share
$2.50
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
35,718,484
Total reported value
$87,637,941
% of total 13F portfolios
0%
Share change
-4,053,643
Value change
-$22,193,175
Number of holders
111
Price from insider filings
$2.50
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 0% $15,910,000 +$120,000 6,364,000 +0.76% Armistice Capital, LLC 31 Dec 2025
GAGNON SECURITIES LLC 9.6% +55% $15,355,268 +$5,406,632 6,142,107 +54% Neil Gagnon 31 Dec 2025
MORGAN STANLEY 3.4% $13,931,448 2,091,809 Morgan Stanley 31 Dec 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.8% -67% $2,863,745 -$6,297,435 1,145,498 -69% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 31 Dec 2025

As of 31 Dec 2025, 111 institutional investors reported holding 35,718,484 shares of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI). This represents 56% of the company’s total 63,703,704 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 10% 6,364,000 +0.76% 0.38% $15,591,800
BlackRock, Inc. 5.4% 3,411,138 -7.4% 0% $8,357,289
GAGNON SECURITIES LLC 4.9% 3,110,575 +38% 1.6% $7,620,909
BANK OF AMERICA CORP /DE/ 3.6% 2,314,222 +2594% 0% $5,669,845
VANGUARD GROUP INC 3.6% 2,273,094 -17% 0% $5,569,081
Gagnon Advisors, LLC 2.4% 1,534,034 +58% 2.4% $3,758,383
MILLENNIUM MANAGEMENT LLC 2.4% 1,502,911 -12% 0% $3,682,132
CIBC Private Wealth Group LLC 2.3% 1,478,830 -12% 0.01% $3,623,134
First Eagle Investment Management, LLC 2.3% 1,462,983 +18% 0.01% $3,584,308
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.8% 1,145,498 -68% 0.01% $2,806,470
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,144,372 -0.18% 0% $2,804,163
STATE STREET CORP 1.6% 994,191 +0.24% 0% $2,435,768
ACADIAN ASSET MANAGEMENT LLC 1% 662,785 +144% 0% $1,620,000
D. E. Shaw & Co., Inc. 0.99% 630,130 -17% 0% $1,543,819
WEBER CAPITAL MANAGEMENT LLC /ADV 0.93% 589,617 0% 1.4% $1,444,562
KOTLER KEVIN 0.74% 474,365 0% 0.86% $1,162,194
NORTHERN TRUST CORP 0.62% 393,765 -8.9% 0% $964,724
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.55% 352,444 -15% 0% $863,488
GSA CAPITAL PARTNERS LLP 0.55% 347,755 +213% 0.07% $852,000
RAYMOND JAMES FINANCIAL INC 0.51% 322,942 +828% 0% $791,208
UBS Group AG 0.46% 293,929 +3.7% 0% $720,126
DIMENSIONAL FUND ADVISORS LP 0.43% 273,376 +12% 0% $669,926
DEUTSCHE BANK AG\ 0.39% 251,049 -73% 0% $615,070
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.38% 242,411 -2.8% 0% $707,840
Birchview Capital, LP 0.36% 226,947 +28% 0.33% $556,020

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 35,718,484 $87,637,941 -$22,193,175 $2.45 111
2025 Q3 38,823,239 $260,292,697 +$3,224,800 $6.71 117
2025 Q2 38,411,285 $225,932,843 +$594,572 $5.88 122
2025 Q1 37,892,233 $314,933,438 +$6,396,329 $8.39 136
2024 Q4 37,307,543 $277,767,394 -$15,594,697 $7.44 133
2024 Q3 39,629,299 $229,799,434 +$2,450,302 $5.80 133
2024 Q2 39,705,068 $264,072,594 -$75,189,680 $6.65 126
2024 Q1 41,245,049 $537,228,351 +$3,488,774 $13.05 129
2023 Q4 41,010,068 $522,886,552 +$21,281,231 $12.75 126
2023 Q3 39,193,648 $513,809,790 -$36,596,248 $13.11 121
2023 Q2 38,926,750 $995,556,262 +$84,284,218 $25.58 135
2023 Q1 35,535,142 $895,139,591 +$184,017,260 $25.19 122
2022 Q4 26,874,663 $617,852,430 +$44,023,715 $22.99 105
2022 Q3 26,104,333 $576,118,458 +$73,324,010 $22.07 90
2022 Q2 23,108,213 $331,376,313 +$38,889,452 $14.34 81
2022 Q1 20,370,513 $385,285,843 +$38,473,149 $18.91 74
2021 Q4 17,228,093 $320,930,460 +$66,992,636 $18.64 74
2021 Q3 13,036,758 $350,676,095 -$6,970,436 $26.90 61
2021 Q2 13,009,799 $406,683,468 +$406,677,512 $31.26 70
2021 Q1 179 $6,000 $33.52 1
2020 Q4 179 $6,000 $33.52 1
2020 Q3 179 $6,000 $33.52 1
2020 Q2 179 $6,000 $33.52 1
2020 Q1 179 $6,000 $33.52 1
2019 Q4 179 $6,000 $33.52 1
2019 Q3 179 $6,000 $33.52 1
2019 Q2 179 $6,000 $33.52 1
2019 Q1 179 $6,000 $33.52 1